AU1684999A - Chymase inhibitors - Google Patents

Chymase inhibitors

Info

Publication number
AU1684999A
AU1684999A AU16849/99A AU1684999A AU1684999A AU 1684999 A AU1684999 A AU 1684999A AU 16849/99 A AU16849/99 A AU 16849/99A AU 1684999 A AU1684999 A AU 1684999A AU 1684999 A AU1684999 A AU 1684999A
Authority
AU
Australia
Prior art keywords
chymase inhibitors
chymase
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16849/99A
Inventor
Fumihiko Akahoshi
Atsuyuki Ashimori
Masahiro Eda
Hajime Fukuyama
Teruaki Imada
Masahide Nakajima
Tatsuyuki Ootsuka
Hiroshi Sakashita
Mikio Tanaka
Takuya Yoshimura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Welfide Corp
Original Assignee
Welfide Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Welfide Corp filed Critical Welfide Corp
Publication of AU1684999A publication Critical patent/AU1684999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU16849/99A 1997-12-22 1998-12-21 Chymase inhibitors Abandoned AU1684999A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP9-353572 1997-12-22
JP35357297 1997-12-22
PCT/JP1998/005786 WO1999032459A1 (en) 1997-12-22 1998-12-21 Chymase inhibitors

Publications (1)

Publication Number Publication Date
AU1684999A true AU1684999A (en) 1999-07-12

Family

ID=18431753

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16849/99A Abandoned AU1684999A (en) 1997-12-22 1998-12-21 Chymase inhibitors

Country Status (2)

Country Link
AU (1) AU1684999A (en)
WO (1) WO1999032459A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6972296B2 (en) 1999-05-07 2005-12-06 Encysive Pharmaceuticals Inc. Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
AU7954900A (en) * 1999-10-25 2001-05-08 Senju Pharmaceutical Co., Ltd. Tension-relieving agents for ciliary muscle
AU2001280590A1 (en) * 2000-07-18 2002-01-30 Neurogen Corporation 5-substituted 2-aryl-4-pyrimidinones
WO2002051815A1 (en) * 2000-12-26 2002-07-04 Ono Pharmaceutical Co., Ltd. Pyrimidine derivatives and process for preparing the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100400639B1 (en) * 1995-04-27 2003-12-31 미쯔비시 웰 파마 가부시키가이샤 Heterocyclic amide compounds and their medicinal uses
JPH107661A (en) * 1996-06-20 1998-01-13 Green Cross Corp:The New heterocyclic amide compound and its medicinal use

Also Published As

Publication number Publication date
WO1999032459A1 (en) 1999-07-01

Similar Documents

Publication Publication Date Title
AU6477498A (en) Scale inhibitors
ZA98376B (en) Sulfamide-metalloprotease inhibitors
GB2321641B (en) Sulfamide-metalloprotease inhibitors
AU3140695A (en) 1h-indole-1-functional spla2 inhibitors
EP0820453A4 (en) Thrombin inhibitors
EP0835109A4 (en) Pyridinone-thrombin inhibitors
EP0969840A4 (en) Thrombin inhibitors
AU4787596A (en) Thrombin inhibitors
AU1301697A (en) Tyrosin-derivate as alpha-v-integrin inhibitors
AU3102397A (en) Metalloprotease inhibitors
AU7497596A (en) Thrombin inhibitors
EP0971891A4 (en) Thrombin inhibitors
AU7139598A (en) Protease inhibitors
AU2723099A (en) Tryptase inhibitors
AU8997498A (en) Tryptase inhibitor
AU6422798A (en) Stabilized urease inhibitor
AU1013997A (en) Amylase inhibitors
AU9300298A (en) Protease inhibitors
AU3042697A (en) Thrombin inhibitors
AUPP076797A0 (en) Phospholipase inhibitor
AU2373600A (en) Novel spla2 inhibitors
AU6049796A (en) Lysyloxidase inhibitors
AU4618197A (en) Thrombin inhibitors
AU2908197A (en) Thrombin inhibitors
AU1684999A (en) Chymase inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase